BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

893 related articles for article (PubMed ID: 33159370)

  • 21. Ultrasound prediction of adverse perinatal outcome at diagnosis of late-onset fetal growth restriction.
    Dall'Asta A; Stampalija T; Mecacci F; Minopoli M; Schera GBL; Cagninelli G; Ottaviani C; Fantasia I; Barbieri M; Lisi F; Simeone S; Ghi T; Frusca T
    Ultrasound Obstet Gynecol; 2022 Mar; 59(3):342-349. PubMed ID: 34159652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):194-202. PubMed ID: 26094952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal growth assessment for prediction of adverse perinatal outcome in fetuses suspected to be small-for-gestational age.
    Caradeux J; Eixarch E; Mazarico E; Basuki TR; Gratacos E; Figueras F
    Ultrasound Obstet Gynecol; 2018 Sep; 52(3):325-331. PubMed ID: 28782171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using fetal abdominal circumference growth velocity in the prediction of adverse outcome in near-term small-for-gestational-age fetuses.
    Cavallaro A; Veglia M; Svirko E; Vannuccini S; Volpe G; Impey L
    Ultrasound Obstet Gynecol; 2018 Oct; 52(4):494-500. PubMed ID: 29266519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of fetal growth restriction using estimated fetal weight vs a combined screening model in the third trimester.
    Miranda J; Rodriguez-Lopez M; Triunfo S; Sairanen M; Kouru H; Parra-Saavedra M; Crovetto F; Figueras F; Crispi F; Gratacós E
    Ultrasound Obstet Gynecol; 2017 Nov; 50(5):603-611. PubMed ID: 28004439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antenatal detection of fetal growth restriction and risk of stillbirth: population-based case-control study.
    Ego A; Monier I; Skaare K; Zeitlin J
    Ultrasound Obstet Gynecol; 2020 May; 55(5):613-620. PubMed ID: 31364201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical utility of third-trimester uterine artery Doppler in the prediction of brain hemodynamic deterioration and adverse perinatal outcome in small-for-gestational-age fetuses.
    Cruz-Martinez R; Savchev S; Cruz-Lemini M; Mendez A; Gratacos E; Figueras F
    Ultrasound Obstet Gynecol; 2015 Mar; 45(3):273-8. PubMed ID: 25346413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Added value of cerebro-placental ratio and uterine artery Doppler at routine third trimester screening as a predictor of SGA and FGR in non-selected pregnancies.
    Rial-Crestelo M; Martinez-Portilla RJ; Cancemi A; Caradeux J; Fernandez L; Peguero A; Gratacos E; Figueras F
    J Matern Fetal Neonatal Med; 2019 Aug; 32(15):2554-2560. PubMed ID: 29447050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of third-trimester cerebroplacental ratio and uterine artery Doppler indices as predictors of stillbirth and perinatal loss.
    Khalil A; Morales-Roselló J; Townsend R; Morlando M; Papageorghiou A; Bhide A; Thilaganathan B
    Ultrasound Obstet Gynecol; 2016 Jan; 47(1):74-80. PubMed ID: 26327300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of Delphi procedure consensus criteria for defining fetal growth restriction.
    Molina LCG; Odibo L; Zientara S; Običan SG; Rodriguez A; Stout M; Odibo AO
    Ultrasound Obstet Gynecol; 2020 Jul; 56(1):61-66. PubMed ID: 31520557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians.
    Vayssière C; Sentilhes L; Ego A; Bernard C; Cambourieu D; Flamant C; Gascoin G; Gaudineau A; Grangé G; Houfflin-Debarge V; Langer B; Malan V; Marcorelles P; Nizard J; Perrotin F; Salomon L; Senat MV; Serry A; Tessier V; Truffert P; Tsatsaris V; Arnaud C; Carbonne B
    Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():10-8. PubMed ID: 26207980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced growth velocity from the mid-trimester is associated with placental insufficiency in fetuses born at a normal birthweight.
    Kennedy LM; Tong S; Robinson AJ; Hiscock RJ; Hui L; Dane KM; Middleton AL; Walker SP; MacDonald TM
    BMC Med; 2020 Dec; 18(1):395. PubMed ID: 33357243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of small for gestational age neonates: screening by maternal factors, fetal biometry, and biomarkers at 35-37 weeks' gestation.
    Ciobanu A; Rouvali A; Syngelaki A; Akolekar R; Nicolaides KH
    Am J Obstet Gynecol; 2019 May; 220(5):486.e1-486.e11. PubMed ID: 30707967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebroplacental ratio assessment in early labor in uncomplicated term pregnancy and prediction of adverse perinatal outcome: prospective multicenter study.
    Dall'Asta A; Ghi T; Rizzo G; Cancemi A; Aloisio F; Arduini D; Pedrazzi G; Figueras F; Frusca T
    Ultrasound Obstet Gynecol; 2019 Apr; 53(4):481-487. PubMed ID: 29900608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fetal neurosonography detects differences in cortical development and corpus callosum in late-onset small fetuses.
    Paules C; Miranda J; Policiano C; Crovetto F; Youssef L; Hahner N; Nakaki A; Crispi F; Gratacós E; Eixarch E
    Ultrasound Obstet Gynecol; 2021 Jul; 58(1):42-47. PubMed ID: 33438307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is cerebroplacental ratio a marker of impaired fetal growth velocity and adverse pregnancy outcome?
    Khalil A; Morales-Rosello J; Khan N; Nath M; Agarwal P; Bhide A; Papageorghiou A; Thilaganathan B
    Am J Obstet Gynecol; 2017 Jun; 216(6):606.e1-606.e10. PubMed ID: 28189607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of fetal growth trajectory identifies infants at high risk of perinatal mortality.
    Larsen ML; Krebs L; Hoei-Hansen CE; Kumar S
    Ultrasound Obstet Gynecol; 2024 Jun; 63(6):764-771. PubMed ID: 38339783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of fetuses with apparent normal growth and abnormal cerebroplacental ratio: A risk-based approach near term.
    Morales-Roselló J; Khalil A; Martínez-Varea A
    Acta Obstet Gynecol Scand; 2024 Feb; 103(2):334-341. PubMed ID: 38050342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical tests of placental function versus ultrasound assessment of fetal size for stillbirth and small-for-gestational-age infants.
    Heazell AE; Hayes DJ; Whitworth M; Takwoingi Y; Bayliss SE; Davenport C
    Cochrane Database Syst Rev; 2019 May; 5(5):CD012245. PubMed ID: 31087568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Placental growth factor and fetoplacental Doppler indices in combination predict preterm birth reliably in pregnancies complicated by fetal growth restriction.
    Hong J; Crawford K; Cavanagh E; da Silva Costa F; Kumar S
    Ultrasound Obstet Gynecol; 2024 May; 63(5):635-643. PubMed ID: 37820083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.